Bal Pharma fundamental analysis

BALPHARMA

69.16

2.33 (-3.26%)
Last updated on 13 Mar, 2026 | 15:29 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bal Pharma Fundamentals

P/E Ratio

14.1

P/B Ratio

1.43

Div. Yield

1.67

Sector P/E

60.72

Sector P/B

2.7

Sec. Div. Yield

0.58

Bal Pharma Fundamentals is currently trading with a P/E Ratio of 14.1, compared to the sector average of 60.72. Its P/B Ratio stands at 1.43, while the sector’s is 2.7. In terms of returns, the stock offers a Dividend Yield of 1.67%, which is than the sector’s 0.58%.

Bal Pharma Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Bal Pharma reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost